Evidence map›Paper›PMID 40599797›Full record

ArticleFrontiers in pharmacology2025

Pulmonary delivery of excipient-free tobramycin DPIs for the treatment of

Song Cheng, Haozhou Huang, Zhihao Zhang, Mateng Chen, Yulong Zhang, Mengxing Lin, Gang Yang, Lynda Thubelihle Kanye, Qingzhen Zhang, Ning Xue and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Song Cheng *School of Engineering, China Pharmaceutical University, Nanjing, China.
Haozhou Huang *Courant Institute of Mathematical Sciences, New York University, New York, NY, United States.
Zhihao ZhangSchool of Engineering, China Pharmaceutical University, Nanjing, China.
Mateng ChenSchool of Engineering, China Pharmaceutical University, Nanjing, China.
Yulong ZhangSchool of Engineering, China Pharmaceutical University, Nanjing, China.
Mengxing LinEastern Institute for Advanced Study, Eastern Institute of Technology, Ningbo, China.
Gang YangEastern Institute for Advanced Study, Eastern Institute of Technology, Ningbo, China.
Lynda Thubelihle KanyeSchool of Engineering, China Pharmaceutical University, Nanjing, China.
Qingzhen ZhangSuzhou Inhal Pharma Co., Ltd, Suzhou, Jiangsu, China.
Ning XueDepartment of Computer Science, University of Nottingham Ningbo China, Ningbo, Zhejiang, China.
Kaiqi ShiSuzhou Inhal Pharma Co., Ltd, Suzhou, Jiangsu, China.
Bin DongSchool of Engineering, China Pharmaceutical University, Nanjing, China.
Hanhan LiSchool of Engineering, China Pharmaceutical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

dry powder inhalations (DPIs)Pseudomonas aeruginosa infectionpulmonary drug deliveryspray freeze-drying (SFD)tobramycin

Identifiers

PMID40599797
PMCPMC12208834

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.